Good evening :)
Place Order
Add to Watchlist

Bliss GVS Pharma Ltd

BLISSGVS

Bliss GVS Pharma Ltd

BLISSGVS
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,117 cr, stock is ranked 1,307
High RiskStock is 3.94x as volatile as Nifty
103.870.82% (+0.84)
103.870.82% (+0.84)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,117 cr, stock is ranked 1,307
High RiskStock is 3.94x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,117 cr, stock is ranked 1,307
High RiskStock is 3.94x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
14.801.220.47%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
41.345.960.61%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Bliss GVS Pharma Limited is engaged in developing, manufacturing and marketing pharmaceutical formulations.

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Lower than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -1.77%, vs industry avg of 8.34%

Decreasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share decreased from 0.41% to 0.24%

Lower than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 3.81%, vs industry avg of 9.77%

Loading...

Financial YearFY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue571.24810.94841.18936.20728.50597.43778.94769.38798.98798.98
Raw Materialssubtract262.55368.69391.70618.79435.67341.59420.18374.38648.82648.82
Power & Fuel Costsubtract4.725.585.494.765.888.148.257.13
Employee Costsubtract33.7461.3569.2342.3253.6968.0976.1586.17
Selling & Administrative Expensessubtract67.19117.9087.5749.9645.3044.9180.6578.55
Operating & Other expensessubtract22.9842.1997.7225.1038.837.82117.4888.03
Depreciation/Amortizationsubtract13.2620.1421.388.9412.5917.2317.3318.6726.3826.38
Interest & Other Itemssubtract18.6119.6922.804.417.575.514.7410.366.916.91
Taxes & Other Itemssubtract65.7193.3686.5158.1931.7135.6339.1335.2241.4141.41
EPS8.007.955.7012.009.436.641.456.827.237.25
DPS0.500.601.001.000.500.500.500.500.500.50
Payout ratio0.060.080.180.080.050.080.340.070.070.07

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2019

Annual report

PDF

Investor Presentation

May 21PDF
Feb 1PDF
Nov 3PDF
Aug 9PDF
FY 2020

Annual report

PDF

Investor Presentation

Aug 21PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Bliss GVS Pharma Ltd14.801.220.47%
Sun Pharmaceutical Industries Ltd37.256.010.91%
Cipla Ltd29.125.060.87%
Zydus Lifesciences Ltd28.055.500.28%

Price Comparison

Compare BLISSGVS with any stock or ETF
Compare BLISSGVS with any stock or ETF
BLISSGVS
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Increased Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has increased by 1.48%

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding34.97%0.00%6.59%14.73%43.71%

Jun 2023

Sep 2023

Dec 2023

Mar 2024

Shareholding History

Dec '22MarJunSepDec '23Mar16.53%16.60%16.50%16.31%15.35%14.73%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No Dividend Cuts

Dividends are the portion of earnings that a company distributes to all its shareholders every year

BLISSGVS has increased or maintained dividend levels over the last 5 years

Dividend Yield

Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation

Current dividend yield is 0.47%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹4.66 every year

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

Cash Dividend

Ex DateEx DateJul 18, 2024

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 18, 2024

Past Dividends

Cash Dividend

Ex DateEx DateJul 12, 2023

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jul 12, 2023

Cash Dividend

Ex DateEx DateJun 20, 2022

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Jun 20, 2022

Cash Dividend

Ex DateEx DateSep 13, 2021

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 13, 2021

Cash Dividend

Ex DateEx DateSep 17, 2020

Final
Final | Div/Share: ₹0.50

Dividend/Share

0.50

Ex DateEx Date

Sep 17, 2020

Cash Dividend

Ex DateEx DateSep 12, 2019

Final
Final | Div/Share: ₹1.00

Dividend/Share

1.00

Ex DateEx Date

Sep 12, 2019